Century Health, a pioneer in applying AI to real-world clinical data to accelerate research, announced a collaboration with Juan Pablo (JP) Arab, M.D., Director of Alcohol Sciences at the ...

Targeting organ‑specific gene “switches” can reverse key markers of liver aging in mice, suggesting aging might be slowed one ...

Over one billion people worldwide are over 60, and the population is projected to more than double by 2050. But as more ...

Certainly! Here's the description with all links removed: Emma Dauster: Writer Justine Ghai: Fact Checker Savannah Geary: ...

This week, a group of researchers use nuclear fallout to figure out how old liver cells are, while another gets one step ...

Phase 1 study of INCA33890 and muzastotug expected to begin in 2026 in 3L MSS CRC patientswith and without liver metastases Study will be ...

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...

The tumor microbiota—which includes bacteria, fungi, viruses, and other microorganisms present in tumor tissue—is now ...

In a new study, Northwestern University neurobiologists discovered that gut bacteria and the nose work together to shape ...

Study will be sponsored and conducted by Incyte; Adagene to provide clinical supply of muzastotug ...

Scientists report that what time you exercise can improve blood sugar control and prevents spikes in people with diabetes.

NorthSea Therapeutics B.V. (“NorthSea” or the “Company”), a private, late-stage clinical biotechnology company leveraging its proprietary structurally engineered fatty acids (SEFAs) platform to ...